Orbit’s top pick KEEL is up 60.9% since the engine surfaced it, and 58% of the names on the board now trade above their screened entry. Below the headline, the median return sits at +5.7% and the mean at +6.6% — a spread that says the upper tail is doing real work.

What Orbit is

Orbit is Luna3.ai’s AI-augmented research engine. It blends twelve algorithmic signals with a gradient-boosted machine-learning model, then layers an agentic LLM analyst on top that reads each top pick’s filings and writes a daily thesis tagged with a conviction score and a catalyst-proximity read. Entry price and date freeze the moment a name clears the screen, so what you see below is the actual setup Orbit flagged in real time — not a back-edited record.

The scorecard

Across every screened name, returns since screened span +60.9% at the top to -21.5% at the bottom.

The aggregate read is straightforward. 58% of names on Orbit’s board are above their screened entry, the median return is +5.7%, and the mean is +6.6% — the mean running hotter than the median because the upper tail (KEEL, ONDS, ASPI, RCAT) is contributing outsized gains. Not every screen works, and a portion of the cohort sits below where Orbit first flagged it.

The top 20% since screened

KEEL anchors the board at +60.9% on its rebrand-and-pivot story, ONDS follows at +43.5% on a stack of defense and counter-drone wins, and ASPI rounds out the podium at +41.5% on isotope-chemistry momentum. RCAT (+36.9%) and STUB (+29.2%) hold the second band, with CLSK, ERAS, KTOS, BTDR and JOBY filling out the upper cohort.

The themes cluster cleanly. AI and compute infrastructure runs through KEEL, CLSK and BTDR — three different routes into the same hyperscaler power-and-hosting trade. Defense and autonomous systems show up in RCAT, KTOS and ONDS, all riding accelerating government procurement cycles. ASPI brings the isotope-chemistry angle into medical and nuclear end markets, and ERAS represents the binary-catalyst biotech archetype where a Phase 1 readout can compress months of upside into a single tape.

How to read the board

Orbit’s screen has two parts: a fundamental and quant track screen, and a technical pre-rally screen. The “Source” column tells you which layer first surfaced each name. Tier 1, 2 and 3 are the top conviction layer — names that cleared both parts of the screen and earned an agentic catalyst review on top, with Tier 1 the highest conviction. The “Track H” tag means Orbit’s H fundamental track caught the name and the technical pattern confirmed it, without the agent review the tiers receive. “Agent pick” is a name surfaced directly by the LLM analyst.

Three to know

KEEL (+60.9%). The April rebrand and uplisting from Bitfarms is complete; the legacy BITF ticker has been delisted. Keel is now pivoting from bitcoin mining into HPC and AI hosting, with a Washington site receiving an 18MW conversion under a $128M binding deal. Tier 1 conviction here reflects how cleanly the new identity maps onto the hyperscaler power-shortage trade Orbit’s stack has been tracking.

ONDS (+43.5%). Contract velocity in May has been the story: a $20M border-protection PO, $10M of autonomous systems orders, the FIFA World Cup counter-drone selection, an $8.2M European airport win, and repeat Middle East orders. Q1 printed $50M in revenue (10x year-over-year) with $1.48B of cash, and management is guiding FY26 to north of $390M. An unusually dense catalyst stack for a small-cap defense name.

RCAT (+36.9%). The Quaze Technologies acquisition closed May 20 in a roughly $21M all-stock deal, broadening the drone-platform stack. Black Widow orders from Japan’s Army (173 units) plus a second Asia-Pacific ally added export momentum, and a Q2 print is on the near calendar. Tier 2 conviction reflects a setup where execution risk is real but the forward catalyst path is already lit.

Bottom line

What ties the leaders together is proximity to a near-term catalyst the tape hasn’t fully priced — a rebrand closing, a contract cycle accelerating, a Phase 1 readout queued, a hyperscaler announcement in advanced talks. The next test for Luna3’s Orbit is whether the middle of the cohort can close the gap with the upper tail as the calendar of prints, contract wins and trial data fills in over the coming weeks. These are screened setups, not buy recommendations — read them as a watchlist of where the engine sees catalyst density.

Read next: Intelligence · Trending